SEC Form 4 · accession 0001104659-15-044001
EPIRUS Biopharmaceuticals, Inc. · EPRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William L Hunter
Director
Period of report
Jun 5, 2015
Accepted (ET)
Jun 8, 2015 · 4:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001135906
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Employee Stock Option (Right to Buy)F1 | $6.39 | Jun 5, 2015 | A | 9,000 | A | — | Jun 5, 2025 | Common Stock | 9,000 | 9,000 | D |
Explanation of responses
- F1The shares subject to this option shall vest in equal quarterly installments over the next year, provided Reporting Person provides continuous service to the Issuer through each vesting date.